TEPOXX (tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses
Regulatory decision marks first approval in Japan of an antiviral for the treatment of orthopoxviruses including smallpox, mpox and cowpox […]
TSX News -
Bitfarms Provides December 2024 Production and Operations Update
– Increased hashrate 97% Y/Y to 12.8 EH/s –– Improved efficiency 40% Y/Y to 21 w/TH –– Earned 2,914 BTC […]
TSX News -
Altus Group Completes the Sale of its Property Tax Business to Ryan, LLC
TORONTO, Jan. 02, 2025 (GLOBE NEWSWIRE) — Altus Group Limited (ʺAltus Group”) (TSX: AIF), a leading provider of asset and […]
Immunocore appoints Travis Coy, previously a Non-Executive Director, as its EVP, Chief Financial Officer and Head of Corporate Development
Immunocore appoints Travis Coy, previously a Non-Executive Director, as its EVP, Chief Financial Officer and Head of Corporate Development (OXFORDSHIRE, […]
TSX News -
Alaris Announces TSX Acceptance of Normal Course Issuer Bid
NOT FOR DISTRIBUTION IN THE UNITED STATES.FAILURE TO COMPLY WITH THIS RESTRICTION MAY VIOLATE UNITED STATES SECURITIES LAW. CALGARY, Alberta, […]
Kintavar enters Definitive Agreement to Sell the Fer à Cheval Outfitter
MONTREAL, Jan. 02, 2025 (GLOBE NEWSWIRE) — Kintavar Exploration Inc. (the “Corporation” or “Kintavar”) (TSX-V: KTR), is pleased to announce […]
Digihost Increases Cash Flow Position and Revenues Year Over Year and Provides December 2024 Production Update
MIAMI, Jan. 02, 2025 (GLOBE NEWSWIRE) — Digihost Technology Inc. (“Digihost” or the “Company”) (Nasdaq / TSXV: DGHI), an innovative […]
iBio Expands Cardiometabolic and Obesity Program with Anti-Myostatin Antibody Discovered Using its Proprietary Platform, In-Licensed from AstralBio
SAN DIEGO, Jan. 02, 2025 (GLOBE NEWSWIRE) — iBio, Inc. (NYSEA: IBIO), an AI-driven innovator of precision antibody immunotherapies, today […]
Critical One – High-Grade, Low-Cost Uranium Recovery at Khan Project
TORONTO, Jan. 02, 2025 (GLOBE NEWSWIRE) — Critical One Energy Inc. (formerly Madison Metals Inc.) (“Critical One”) (CSE: CRTL) (OTCQB: […]
ANI Pharmaceuticals Announces the FDA Approval and Launch of Prucalopride Tablets with 180-Day CGT Exclusivity
PRINCETON, N.J., Jan. 02, 2025 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that […]
